Establishment Labs Holdings Inc. ESTA
We take great care to ensure that the data presented and summarized in this overview for ESTABLISHMENT LABS HOLDINGS INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ESTA
View all-
Jw Asset Management, LLC Armonk, NY3.19MShares$116 Million62.21% of portfolio
-
Rtw Investments, LP New York, NY2.65MShares$95.9 Million1.82% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.36MShares$85.5 Million6.05% of portfolio
-
Brown Advisory Inc1.9MShares$68.8 Million0.11% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.48MShares$53.5 Million0.01% of portfolio
-
Findell Capital Management LLC New York, NY1.03MShares$37.2 Million22.41% of portfolio
-
Jpmorgan Chase & CO New York, NY903KShares$32.7 Million0.0% of portfolio
-
Cowen And Company, LLC870KShares$31.5 Million0.97% of portfolio
-
Rice Hall James & Associates, LLC793KShares$28.7 Million2.02% of portfolio
-
Morgan Stanley New York, NY701KShares$25.4 Million0.0% of portfolio
Latest Institutional Activity in ESTA
Top Purchases
Top Sells
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Insider Transactions at ESTA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Ann Custin Director |
BUY
Grant, award, or other acquisition
|
Direct |
420
+2.53%
|
$19,320
$46.07 P/Share
|
|
Dec 31
2024
|
Bryan Slotkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
352
+1.38%
|
$16,192
$46.07 P/Share
|
|
Dec 31
2024
|
Leslie Gillin Director |
BUY
Grant, award, or other acquisition
|
Direct |
366
+3.25%
|
$16,836
$46.07 P/Share
|
|
Dec 31
2024
|
Nicholas Sheridan Lewin Director |
BUY
Grant, award, or other acquisition
|
Direct |
542
+0.05%
|
$24,932
$46.07 P/Share
|
|
Dec 31
2024
|
Dennis E Condon Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+3.08%
|
$13,708
$46.07 P/Share
|
|
Dec 31
2024
|
Edward J Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
406
+0.13%
|
$18,676
$46.07 P/Share
|
|
Dec 04
2024
|
Jw Asset Management, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
100,000
-3.13%
|
$4,500,000
$45.15 P/Share
|
|
Sep 30
2024
|
Ann Custin Director |
BUY
Grant, award, or other acquisition
|
Direct |
447
+2.76%
|
$19,221
$43.27 P/Share
|
|
Sep 30
2024
|
Edward J Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
433
+0.14%
|
$18,619
$43.27 P/Share
|
|
Sep 30
2024
|
Nicholas Sheridan Lewin Director |
BUY
Grant, award, or other acquisition
|
Direct |
577
+0.05%
|
$24,811
$43.27 P/Share
|
|
Sep 30
2024
|
Dennis E Condon Director |
BUY
Grant, award, or other acquisition
|
Direct |
318
+3.38%
|
$13,674
$43.27 P/Share
|
|
Sep 30
2024
|
Bryan Slotkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
375
+1.49%
|
$16,125
$43.27 P/Share
|
|
Sep 30
2024
|
Leslie Gillin Director |
BUY
Grant, award, or other acquisition
|
Direct |
389
+3.57%
|
$16,727
$43.27 P/Share
|
|
Aug 20
2024
|
Filippo Caldini President |
BUY
Grant, award, or other acquisition
|
Direct |
9,078
+50.0%
|
-
|
|
Jul 11
2024
|
Quiros Juan Jose Chacon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,641
-1.7%
|
$163,845
$45.04 P/Share
|
|
Jul 09
2024
|
Quiros Juan Jose Chacon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
654
-0.3%
|
$29,430
$45.0 P/Share
|
|
Jul 08
2024
|
Quiros Juan Jose Chacon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,866
-1.77%
|
$173,970
$45.01 P/Share
|
|
Jul 01
2024
|
Quiros Juan Jose Chacon Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,839
-3.03%
|
$307,755
$45.3 P/Share
|
|
Jun 30
2024
|
Leslie Gillin Director |
BUY
Grant, award, or other acquisition
|
Direct |
359
+3.42%
|
$16,155
$45.44 P/Share
|
|
Jun 30
2024
|
Ann Custin Director |
BUY
Grant, award, or other acquisition
|
Direct |
426
+2.71%
|
$19,170
$45.44 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 57.2K shares |
|---|
| Open market or private sale | 115K shares |
|---|---|
| Payment of exercise price or tax liability | 875 shares |